Nakagawa Tetsuto, Takahashi Chihiro, Matsuzaki Hitomi, Takeyama Shohei, Sato Shinpei, Sato Ayaka, Kuroda Yoshiyuki, Higashi Hideyoshi
Division of Glyco-Signal Research, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan.
Division of Glyco-Signal Research, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan.
Biochem Biophys Res Commun. 2017 Apr 1;485(2):427-431. doi: 10.1016/j.bbrc.2017.02.061. Epub 2017 Feb 14.
P2Y receptor (P2YR) is a G-protein-coupled receptor (GPCR) that couples with Gαq/11 and is stimulated by ATP and UTP. P2YR is involved in pain, proinflammatory changes, and blood pressure control. Some GPCRs are localized in lipid rafts for interaction with other signaling molecules. In this study, we prepared N-glycan-deficient mutants by mutating the two consensus Asn residues for N-glycosylation to Gln to examine intracellular localization and association with lipid rafts. Western blotting of the wild type (WT) protein and mutants (N9Q, N13Q, N9Q/N13Q) in COS-7 cells showed that both Asn residues were glycosylated in the WT. Fluorescent microscopy analysis showed that WT, N9Q and N13Q were expressed in the endoplasmic reticulum (ER), Golgi body, and cell membrane, but N9Q/N13Q was only found in the ER. WT, N9Q and N13Q moved from the cell surface to endosomes within 15 min after UTP stimulation. WT and the N9Q/N13Q glycosylation-deficient mutant appeared in the detergent insoluble membrane fraction, lipid raft. These findings suggest that P2YR is localized in lipid rafts in the ER during biosynthesis, and that N-glycosylation is required for subsequent expression in the cell membrane. In the presence of epoxomicin, a proteasome inhibitor, there was a significant increase in the level of N9Q/N13Q, which suggests that N-glycan-deficient P2YR undergoes proteasomal degradation.
P2Y受体(P2YR)是一种G蛋白偶联受体(GPCR),它与Gαq/11偶联,并受ATP和UTP刺激。P2YR参与疼痛、促炎变化和血压控制。一些GPCR定位于脂筏中,以便与其他信号分子相互作用。在本研究中,我们通过将两个N-糖基化的共有Asn残基突变为Gln来制备N-聚糖缺陷型突变体,以检查细胞内定位以及与脂筏的关联。对COS-7细胞中的野生型(WT)蛋白和突变体(N9Q、N13Q、N9Q/N13Q)进行蛋白质印迹分析表明,WT中的两个Asn残基均被糖基化。荧光显微镜分析显示,WT、N9Q和N13Q在内质网(ER)、高尔基体和细胞膜中表达,但仅在ER中发现N9Q/N13Q。在UTP刺激后15分钟内,WT、N9Q和N13Q从细胞表面转移至内体。WT和N9Q/N13Q糖基化缺陷型突变体出现在去污剂不溶性膜组分(脂筏)中。这些发现表明,P2YR在生物合成过程中定位于ER中的脂筏,并且N-糖基化是其随后在细胞膜中表达所必需的。在蛋白酶体抑制剂环氧霉素存在的情况下,N9Q/N13Q的水平显著增加,这表明N-聚糖缺陷型P2YR会经历蛋白酶体降解。